Men's Health

Chirila C, Earnshaw SR, Black L, McDade CL, Roskell NS, Shannon PR, Montorsi F, Andriole GL. Economic analysis: randomized, placebo-controlled clinical trial of dutasteride in men at high risk for prostate cancer. J Cancer Sci Ther. 2011;S3(004). doi: 10.4172/1948-5956.S3-004

Objective: Given the economic burden of prostate cancer (PCa), a PCa risk-reduction medication would be desirable. A within-trial economic analysis of the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study was performed.

Methods: REDUCE, a 4-year, randomized, double-blind, placebo-controlled, parallel-group clinical trial, compared efficacy and safety of dutasteride 0.5 mg daily and placebo to reduce the risk of PCa in men at increased risk. Resource use was prospectively collected; costs from standard costing sources were applied.

Rosen RC, Wincze J, Mollen MD, Gondek K, McLeod LD, Fisher WA. Responsiveness and minimum important differences for the erection quality scale. J Urol. 2007 Nov 1;178(5):2076-81.

Purpose
We evaluated the responsiveness and treatment sensitivity of the Erection Quality Scale, and provided further psychometric validation of this scale.

Materials and Methods

Overland GB, Vatten L, Rhodes T, DeMuro C, Jacobsen G, Vada K, Angelsen A, Girman CJ. Lower urinary tract symptoms, prostate volume and uroflow in Norwegian community men. Eur Urol. 2001 Jan 1;39(1):36-41.

Objective: To describe lower urinary tract symptoms, prostate volume and peak urinary flow rate, and investigate the relationships among urological variables in a community sample of Norwegian men.

Materials and Methods: A cross-sectional study of 611 men, aged 55-70 years, who underwent a clinical urological examination including uroflowmetry, residual urine measurement, and transrectal ultrasonography of the prostate. All the men completed a questionnaire which included the International Prostate Symptom Score (IPSS).

Demuro-Mercon C, Rhodes T, Girman CJ, Vatten L. Male-pattern hair loss in Norwegian men: a community-based study. Dermatology. 2000 Jan 1;200(3):219-22.

BACKGROUND: A Norwegian community study was conducted as an add-on to a large general health survey in Trondlag County, Norway, to characterize the cross-sectional relationship of patient perceptions with the degree of hair loss. METHODS: All members of the community were invited to participate in the general health survey and male participants, aged 20-50 years (n = 7,250), regardless of their degree of hair loss, were asked to complete a mail-based questionnaire.

Sorensen HT, Pedersen L, Norgaard M, Wogelius P, Rothman KJ. Maternal asthma, preeclampsia and risk of hypospadias. Epidemiology. 2005 Nov 1;16(6):806-7.

No abstract available at this time

Williams VSL, Baldwin DS, Hogue SL, Fehnel SE, Hollis KA, Edin HM. Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 European countries: a cross-sectional patient survey. J Clin Psychiatry. 2006 Feb 1;67(2):204-10.


OBJECTIVE: Sexual dysfunction is a common side effect of antidepressant treatment, but recognition of the problem is variable. The aim of this study was to estimate the prevalence and impact of sexual dysfunction during antidepressant treatment in 2 European countries.

Wincze J, Fehnel SE, McLeod LD, Granger AL, Merchant S. Development and initial testing of a new patient-reported questionnaire: erection quality scale. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research Sixth Annual European Congress; November 1, 2003. Barcelona, Spain. [abstract] Value Health. 2003 Nov; 6(6):709.


Davis KL, Mauskopf J, Chow W, Chao J, Seal B. Titration and persistence with tamsulosin among men with benign prostatic hyperplasia in a large managed care population. Poster presented at the Academy of Managed Care Pharmacy 18th Annual Meeting; April 8, 2006.

INTRODUCTION: This study assessed patterns of titration and persistence with tamsulosin, the first FDA approved selective alpha-adrenergic blocker indicated for the treatment of benign prostatic hyperplasia (BPH), in a managed care population.

METHODS: This retrospective analysis evaluated dosing and refill patterns from medical claims of 33,671 men in the PharMetrics database with a BPH diagnosis and treatment with tamsulosin between 10/8/99 and 1/31/05.

Grzywacz JG, Quandt SA, Early J, Tapia J, Graham CN, Arcury TA. Leaving Family for Work: ambivalence and Mental Health Among Mexican Migrant Farmworker Men. J Immigr Minor Health. 2006 Jan 1;8(1):85-97.

Abstract Men migrating to the United States from Mexico and Central America confront opposing family norms. They need to leave their families to gain family economic security; yet, leaving renders their families vulnerable. We examined the mental health implications of the opposing family norms inherent in migration using an ambivalence framework. We interviewed 60 Latino migrant farmworkers working in North Carolina. Most were from Mexico; each had left a wife and children in his countryof origin. Analysis indicated that family ambivalence was common.

Skriver MV, Pedersen L, Stang P, Lund L, Rothman KJ, Sorensen HT. The month of birth does not affect the risk of hypospadias. Eur J Epidemiol. 2004 Dec 1;19(12):1135-6.

We studied the pattern of annual cyclical variation of hypospadia by month of birth for all boys born in Denmark after 1983 and hospitalized with hypospadias. We found little indication of any seasonal pattern, with a peak to low ratio of 1.06 (95% CI: 1.00-1.17).

How Can We Help You?